Metabolomic Analysis, a Potential Tool to Direct Treatment With Adalimumab in Crohn's Disease (CD)
Phase of Trial: Phase II
Latest Information Update: 02 Apr 2014
At a glance
- Drugs Adalimumab (Primary)
- Indications Crohn's disease
- Focus Biomarker; Therapeutic Use
- Acronyms MB
- 07 Jun 2017 Biomarkers information updated
- 04 Feb 2014 Status changed from recruiting to completed according to ClinicalTrials.gov record.
- 28 Jan 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.